These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37733356)

  • 1. Efficacy of Gabapentin For Post-COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial.
    Mahadev A; Hentati F; Miller B; Bao J; Perrin A; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2023 Dec; 149(12):1111-1119. PubMed ID: 37733356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Saline Nasal Irrigation Plus Theophylline for Treatment of COVID-19-Related Olfactory Dysfunction: The SCENT2 Phase 2 Randomized Clinical Trial.
    Gupta S; Lee JJ; Perrin A; Khan A; Smith HJ; Farrell N; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2022 Sep; 148(9):830-837. PubMed ID: 35797024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Combined Visual-Olfactory Training With Patient-Preferred Scents as Treatment for Patients With COVID-19 Resultant Olfactory Loss: A Randomized Clinical Trial.
    Khan AM; Piccirillo J; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2023 Feb; 149(2):141-149. PubMed ID: 36580304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stellate Ganglion Block for the Treatment of COVID-19-Induced Olfactory Dysfunction: A Prospective Pilot Study.
    Peterson AM; Miller BJ; Kallogjeri D; Piccirillo JF; Kukuljan S; Roland LT; Schneider JS; Crock LW; Farrell NF
    Otolaryngol Head Neck Surg; 2024 Jan; 170(1):272-276. PubMed ID: 37750244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
    O'Byrne L; Webster KE; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013876. PubMed ID: 34291813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter to the editor: Study Summary - Randomized Control Trial of Omega-3 Fatty Acid Supplementation for the Treatment of COVID-19 Related Olfactory Dysfunction.
    Lerner D; Garvey K; Arrighi-Allisan A; Filimonov A; Filip P; Liu K; Ninan S; Schaberg M; Colley P; Del Signore A; Govindaraj S; Iloreta AM
    Trials; 2020 Nov; 21(1):942. PubMed ID: 33225989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Perioperative Gabapentin Use on Postsurgical Pain in Patients Undergoing Head and Neck Mucosal Surgery: A Randomized Clinical Trial.
    Townsend M; Liou T; Kallogjeri D; Schoer M; Scott-Wittenborn N; Lindburg M; Bottros M; Jackson RS; Nussenbaum B; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):959-966. PubMed ID: 29710075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
    Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013877. PubMed ID: 36063364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Olfactory Dysfunction as a Marker of Frailty and Postoperative Outcomes in Head and Neck Cancer.
    Mady LJ; De Ravin E; Vohra V; Lu J; Newman JG; Hall DE; Dalton PH; Rowan NR
    JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):828-836. PubMed ID: 37498617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.
    Anton RF; Latham P; Voronin K; Book S; Hoffman M; Prisciandaro J; Bristol E
    JAMA Intern Med; 2020 May; 180(5):728-736. PubMed ID: 32150232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
    Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013877. PubMed ID: 34291812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural trajectory of recovery of COVID-19 associated olfactory loss.
    Khan AM; Lee J; Rammaha T; Gupta S; Smith H; Kannampallil T; Farrell N; Kallogjeri D; Piccirillo JF
    Am J Otolaryngol; 2022; 43(5):103572. PubMed ID: 35969913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial.
    Hah J; Mackey SC; Schmidt P; McCue R; Humphreys K; Trafton J; Efron B; Clay D; Sharifzadeh Y; Ruchelli G; Goodman S; Huddleston J; Maloney WJ; Dirbas FM; Shrager J; Costouros JG; Curtin C; Carroll I
    JAMA Surg; 2018 Apr; 153(4):303-311. PubMed ID: 29238824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial.
    Di Stadio A; Gallina S; Cocuzza S; De Luca P; Ingrassia A; Oliva S; Sireci F; Camaioni A; Ferreli F; Mercante G; Gaino F; Pace GM; La Mantia I; Brenner MJ
    Eur Arch Otorhinolaryngol; 2023 Nov; 280(11):4949-4961. PubMed ID: 37380908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial.
    Horne AW; Vincent K; Hewitt CA; Middleton LJ; Koscielniak M; Szubert W; Doust AM; Daniels JP;
    Lancet; 2020 Sep; 396(10255):909-917. PubMed ID: 32979978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.